This report provides comprehensive information on the current therapeutic developmental pipeline of Trino Therapeutics Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
1. Trino Therapeutics Ltd - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Trino Therapeutics Ltd - Product Pipeline Review - 2014’, provides an overview of the Trino Therapeutics
Ltd’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Trino Therapeutics Ltd’s, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s
team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated
with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking
ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Trino Therapeutics Ltd including business description, key information and facts, and its locations and subsidiaries The
report reviews current pipeline of Trino Therapeutics Ltd’s human therapeutic division and enlists all their major and minor projects The report features
product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company
statement Latest news and deals relating to the Trino Therapeutics Ltd’s pipeline products
Reasons to buy
Evaluate Trino Therapeutics Ltd’s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Trino
Therapeutics Ltd in its therapy areas of focus Identify new drug targets and therapeutic classes in the Trino Therapeutics Ltd’s R&D portfolio and develop
key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop
strategic initiatives by understanding the focus areas of Trino Therapeutics Ltd and exploit collaboration and partnership opportunities Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by
identifying the most promising pipeline of Trino Therapeutics Ltd Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Trino
Therapeutics Ltd and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Content
trino Therapeutics Ltd Snapshot
trino Therapeutics Ltd Overview
key Information
key Facts
trino Therapeutics Ltd - Research And Development Overview
key Therapeutic Areas
trino Therapeutics Ltd - Pipeline Review
pipeline Products By Stage Of Development
pipeline Products - Monotherapy
trino Therapeutics Ltd - Pipeline Products Glance
trino Therapeutics Ltd - Early Stage Pipeline Products
preclinical Products/combination Treatment Modalities
trino Therapeutics Ltd - Drug Profiles
ph-44
product Description
mechanism Of Action
r&d Progress
ph-46a
product Description
mechanism Of Action
r&d Progress
ph-5
product Description
mechanism Of Action
r&d Progress
trino Therapeutics Ltd - Pipeline Analysis
trino Therapeutics Ltd - Pipeline Products By Route Of Administration
trino Therapeutics Ltd - Pipeline Products By Molecule Type
trino Therapeutics Ltd - Recent Pipeline Updates
trino Therapeutics Ltd - Locations And Subsidiaries
head Office
Trino Therapeutics Ltd - Product Pipeline Review - 2014
2. appendix
methodology
coverage
secondary Research
primary Research
expert Panel Validation
contact Us
disclaimer
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Trino Therapeutics Ltd - Product Pipeline Review - 2014
